U.S. Food Stock News

ResMed (RMD) shares recently closed at US$226.14, leading some investors to reassess the company’s valuation after a mixed return profile that includes a small gain over the past month but a negative performance over the past 3 months. See our latest analysis for ResMed. Looking beyond the recent pullback, ResMed’s share price has a 90 day decline alongside a year to date share price return of negative 7.63%, while its 1 year total shareholder return of 8.20% reflects the contribution from...

Eos Energy Enterprises, Inc. and TURBINE-X Energy, Inc. recently entered a Joint Development Agreement to build integrated gas-turbine and Eos Indensity battery systems, targeting up to 2 GWh of storage for AI-focused, private power infrastructure over the next 36 months, with initial deployments planned for 2027. This move positions Eos directly in the power-hungry AI data center segment, using behind-the-meter, firm power solutions to address grid constraints and mission-critical...

Earlier this year, CBRE Group and Meta launched LevelUp, a multiyear program to recruit and train thousands of fiber technicians across multiple U.S. training centers, supporting the build-out of next-generation data center infrastructure. This partnership, combined with analysts’ expectations for higher quarterly earnings and revenue, highlights CBRE’s deepening role in data center-related services and operational execution. Next, we’ll assess how CBRE’s Meta partnership and data center...

Why Chord Energy is on investors’ radar today Chord Energy (CHRD) has been drawing attention after recent share price moves, with the stock up about 2.8% over the past day but showing mixed returns across the week, month and past 3 months. See our latest analysis for Chord Energy. Zooming out from the 2.8% one day share price gain to around $127, Chord Energy’s 90 day share price return of 38.23% and 1 year total shareholder return of 44.06% indicate that momentum has been building rather...

In April 2026, NGL Energy Partners LP announced that its Board of Directors had approved an open-ended unit repurchase program of up to US$100 million of its outstanding limited partnership units. This sizable buyback authorization stands out as a capital allocation move that can tighten the unit count and reflect management’s confidence in the partnership’s outlook. With that backdrop, we’ll now examine how this US$100 million repurchase authorization shapes NGL Energy Partners’ investment...

Why the AACR data on rinzimetostat is on investors’ radar ORIC Pharmaceuticals (ORIC) shares are in focus after the company highlighted new preclinical data for rinzimetostat at the 2026 AACR Annual Meeting, centered on prostate cancer models that include treatment resistant disease. See our latest analysis for ORIC Pharmaceuticals. ORIC’s latest AACR posters on rinzimetostat arrive after a strong year to date, with a 33.29% year to date share price return and a 123.61% 1 year total...

Liberty Energy (LBRT) is drawing attention ahead of its first quarter 2026 earnings, as the company pairs expectations for softer revenue with an improved bottom line and growth in its digiTechnologies and power solutions offerings. See our latest analysis for Liberty Energy. Liberty Energy’s share price has pulled back recently, with a 30 day share price return of 15.55% and a 7 day share price return of 4.73%. However, the 90 day share price return of 31.94% and 1 year total shareholder...

Astec Industries has announced that Chad Hartley will join the company as Group President – Infrastructure Solutions and a member of the Executive Leadership Team on May 11, 2026, bringing experience from leadership roles at Regal Rexnord and Emerson Electric. Hartley’s background spanning operations, supply chain, global sales and marketing, and an expatriate tenure in Shanghai suggests Astec may place greater emphasis on global infrastructure solutions and commercial execution across its...

Camden Property Trust (CPT) has entered into a binding term sheet to settle a class action lawsuit, agreeing to contribute US$53 million to a settlement fund and to adopt specific business practice commitments, subject to court approval. See our latest analysis for Camden Property Trust. After this settlement announcement, Camden Property Trust’s recent share price momentum has been improving, with a 7.60% 1 month share price return. However, the year to date share price return is still...

Stryker (SYK) heads into its upcoming Q1 2026 earnings report with investor attention centered on expected profit growth, recent cyberattack recovery efforts, and the latest leadership move inside its MedSurg and Neurotechnology segment. See our latest analysis for Stryker. Despite the recent leadership change and attention on cyberattack recovery, Stryker’s 1 day share price return of a 1.45% decline and 7 day share price return of a 2.56% decline sit alongside a modest 1 year total...

In April 2026, Frontdoor, Inc. announced that its American Home Shield brand is expanding a six-year partnership with technology provider SkySlope from 4 to 43 states, streamlining the home warranty application process for nearly 175,000 real estate agents and brokers through a single, automated workflow. This move materially strengthens Frontdoor’s integration into real estate transaction workflows, potentially making its home warranty products more embedded and convenient for agents and...

Wave Life Sciences recently received board approval to redomicile its parent company from Singapore to a new Delaware-based entity via a one-for-one share exchange, aiming to cut regulatory burdens and compliance costs, with completion targeted by mid-2026 subject to shareholder and Singapore High Court approvals. This shift to a US domicile could meaningfully reshape Wave’s corporate, tax, and regulatory framework, potentially influencing how it executes its RNA-focused business...

Open Text (NasdaqGS:OTEX) just highlighted its European focus, rolling out data and AI offerings on the AWS European Sovereign Cloud and teaming up with S3NS in France, while refreshing client-facing leadership roles. See our latest analysis for Open Text. These European cloud and data-sovereignty moves arrive after a 7 day share price return of 5.89% and a 30 day gain of 3.50%. However, they sit against a 26.40% year to date decline and a 5 year total shareholder return of 43.47% in the red,...

Septerna, Inc. recently began dosing healthy volunteers in a randomized, placebo-controlled Phase 1 trial of SEP-479, an oral PTH1R agonist for hypoparathyroidism, using single-ascending and multiple-ascending dose designs to assess safety, tolerability, pharmacokinetics and pharmacodynamics. This first-in-human study, which could enroll up to 150 participants and tracks biomarkers such as endogenous PTH and serum calcium, marks a key progression of Septerna’s GPCR-targeted pipeline into...

California Water Service Group (CWT) has attracted fresh attention after recent share price moves, with the stock showing gains over the past week, month, and past 3 months relative to its last close of $46.85. See our latest analysis for California Water Service Group. That recent 4.2% 1 day share price return and 6.7% 30 day share price return sit against a 1 year total shareholder return decline of 5.2%. This suggests short term momentum is improving while longer term returns remain under...

Incyte has reported positive Phase 3 results for tafasitamab (Monjuvi/Minjuvi) in first-line diffuse large B-cell lymphoma, with full data to be presented at the 2026 ASCO Annual Meeting, supporting global regulatory submissions, and separately entered a clinical collaboration with Adagene to test a novel combination therapy in microsatellite stable colorectal cancer in a Phase 1 trial planned for 2026. These advances highlight Incyte’s effort to broaden its oncology portfolio beyond...

Over the last 7 days, the United States market has risen by 3.6%, and over the past year, it has seen a remarkable increase of 39%, with earnings forecasted to grow by 16% annually. In such a thriving environment, identifying stocks that are potentially undervalued can offer opportunities for investors looking to capitalize on discrepancies between current prices and estimated worth.

Context for Vertex Pharmaceuticals after recent share performance Vertex Pharmaceuticals (VRTX) has recently seen its share price under pressure, with a 3.3% decline over the past month and an 8.0% negative total return over the past year. This performance has prompted closer attention from investors. See our latest analysis for Vertex Pharmaceuticals. With the share price at US$439.18 and a 1 year total shareholder return of 8.0% in the red, but a 5 year total shareholder return of 102.4%,...

In recent weeks, CoStar Group’s Homes.com platform released a March report spotlighting the priciest publicly marketed home sales across major U.S. metros, led by a US$170 million Miami estate, with Los Angeles and New York City also registering ultra-luxury transactions. At the same time, hedge fund Third Point publicly exited its CoStar position after criticizing ongoing investment in Homes.com, highlighting growing debate over how the residential push fits within CoStar’s broader business...

Marriott International’s Luxury Collection is partnering with designer Margherita Maccapani Missoni on an immersive Milan Design Week pop-up and capsule fashion collection at Casa Brera, while also advancing its Autograph Collection footprint with the NUMAJ hotel in Saudi Arabia’s AlUla and opening the Noormahal Palace Hotel in Karnal, India. Together, these moves highlight Marriott’s push to deepen its luxury positioning by blending high-end hospitality with fashion-led experiences and...

Aon (NYSE:AON) is back in focus after expanding its Data Center Lifecycle Insurance Program by an additional $1 billion, lifting total capacity to $3.5 billion and extending coverage to existing post-commissioning data centers. See our latest analysis for Aon. Aon’s recent product and dividend announcements come after a mixed period for investors, with the share price at $331.95 and a 30 day share price return of 1.94%, against a year to date share price decline of 3.58% and a 1 year total...

The United States market has shown robust performance, climbing 3.6% in the last week and 39% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, stocks with high insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and strategic direction.

Over the last 7 days, the United States market has risen 3.6%, and over the past year, it has climbed 39%, with earnings expected to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for investors seeking growth at lower price points. By focusing on those with strong balance sheets and solid fundamentals, these stocks can present an underappreciated chance for stability and potential upside in today's market conditions.

In the past week, Griffon reported quarterly results with revenues and adjusted operating income coming in ahead of analyst expectations, even as full-year revenue guidance fell short of consensus and lagged peers. The contrast between a stronger-than-expected quarter and relatively soft guidance has sharpened attention on how much of Griffon’s recent strength is sustainable versus cyclical. With Griffon’s recent revenue beat but softer full-year outlook, we’ll examine how this mixed...